<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190108042293N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-31</date_registration>
      <primary_sponsor>Dental Research Institute of Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Combination of Micro-osteoperforation and a Vibration Device on Orthodontic Tooth Movement</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Combination of Micro-osteoperforation and a Vibration Device on Orthodontic Tooth Movement : A Prospective Randomized Clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53415</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, the "Balanced Block Randomization" method will be used. In this method, 4 blocks (envelopes) of equal size are prepared. In each block, sheets are randomly assigned to the control group (B) and/or the intervention group (A) using the RAND option of Excel software. The randomization process will be performed by the Methodology and Research Consultant of the study and the clinical researcher will not be aware of the type of intervention until the study begins (allocation concealment). The person performing the randomization process, places the letters A as the intervention group and the letters B as the control group on sheets inside the sealed envelopes. These envelopes will be numbered from 1 to 4 . At the beginning of the study and the arrival of patients (participants), envelope 1 to envelope 4 will be used, respectively, and when working on the patient, the envelope will be opened and the type of intervention will be determined.
Randomization unit: Individual
Randomization tool: Excel software, Blinding description: Patients (participants) blinding is not possible because one of the study interventions is vibration that is perceived by the patients. Blinding the clinical researcher is also not possible. Because the responsible persons for data collection and outcome evaluation are different from the practitioner (clinical researcher) and while collecting data and evaluating the outcome, they do not know which control and / or intervention group the patient belongs to, blinding of the persons responsible for data collection and outcome evaluation is possible.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Orthodontic Treatment.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group: receives micro-osteoperforations on both sides (right and left) of the maxilla along with using a C-shaped vibration device (Vpro5, Propel Orthodontics). Intervention 2: The control group: receives micro-osteoperforations on both sides (right and left) of the maxilla without using a vibration device.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual unidentifiable data of the participants including age, sex, type of malocclusion and data obtained from the study such as the effect of intervention on the rate of orthodontic tooth movement.

When:
Access period starts 6 months after the results are published.

To whom:
Faculty members of the universities of medical sciences

Conditions:
Using data for systematic review

Where to obtain:
Applicants can refer to the corresponding author " Dr. Sarvin Sarmadi" to get the study data.
 Postal address: Department of Orthodontics, School of Dentistry, Tehran University of Medical Sciences, North Karegar St., Tehran, Iran.
 Postal code: 1439955991
 Email : sarmadis@sina.tums.ac.ir
Phone : 0098 21 88015801

How to obtain:
After receiving the request of an applicant and consulting the first and the corresponding authors of the article, the documents will be delivered to the applicant within 1 working month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sarvin Sarmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Orthodontics, School of Dentistry, Tehran University of Medical Sciences, North Karegar St, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۹۹۵۵۹۹۱</zip>
        <telephone>+98 21 8801 5801</telephone>
        <email>sarmadis@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sarvin Sarmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Orthodontics, School of Dentistry, Tehran University of Medical Sciences, North Karegar St, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۹۹۵۵۹۹۱</zip>
        <telephone>+98 21 8801 5801</telephone>
        <email>sarmadis@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range : 18 to 45 years
Maxillary canine teeth fully erupted
Need to extract  both first maxillary premolars
Existence of 3 mm space after initial alignment
Good oral hygiene</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Systemic diseases affecting bone metabolism
Take any medication
Periodontal disease
Smoking
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group: receives micro-osteoperforations on both sides (right and left) of the maxilla along with using a C-shaped vibration device (Vpro5, Propel Orthodontics).</i_keyword>
      <i_keyword>The control group: receives micro-osteoperforations on both sides (right and left) of the maxilla without using a vibration device.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Rate of orthodontic tooth movement. Timepoint: At the beginning of the study, immediately before canine retraction, and 28 days after the onset of canine retraction. Method of measurement: Digital caliper with an accuracy of 0.01 millimeter and dental casts.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The level of pain caused by micro-osteoperforation. Timepoint: The day of appliance placement , the day of canine retraction, and subsequently at 24 hours, 7 days, and 28 days after canine retraction. Method of measurement: Numerical rating scale.</sec_outcome>
      <sec_outcome>The level of patient's drooling caused by micro-osteoperforation and the use of a vibration device. Timepoint: The day of appliance placement , the day of canine retraction, and subsequently at 24 hours, 7 days, and 28 days after canine retraction. Method of measurement: Numerical rating scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Dental Research Institute of Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-18</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>North Karegar St , Tehran , Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
